Description: Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-gout, anti-depressant, and anti-malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides fever X for fever; Pain X for pain; Fiber-X, a sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.
Home Page: www.morepen.com
Tower C, DLF Cyber Park
Gurugram,
122016
India
Phone:
91 12 4489 2000
Officers
| Name | Title |
|---|---|
| Mr. Sushil Suri B.Sc., F.C.A., FCA | Chairman & MD |
| Mr. Sanjay Suri | Whole-Time Director |
| Mr. Ajay Kumar Sharma | Chief Financial Officer |
| Mr. Bhola Prasad | General Manager of Process Engineering & Technology Transfer |
| Ms. Sunita Suri | Manager of Administration |
| Mr. Vipul Kumar Srivastava | Company Secretary & Compliance Officer |
| Mr. Vikas Sharma | Functional Head of Talent Acquisition & HRBP |
| Ms. Amita Sharma | Chief Operating Officer of API |
| Mr. Anubhav Suri | Head of Medipath Division |
| Mr. Kushal Suri | Head of International Business Development |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 29.917 |
| Price-to-Book MRQ: | 4.3035 |
| Price-to-Sales TTM: | 2.6895 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 2152 |